Hudson Bay Capital Management
CRL icon

Hudson Bay Capital Management’s Charles River Laboratories CRL Stock Holding History

Hudson Bay Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-135,583
Closed -$14.8M – 783
2017
Q4 		$14.8M Buy
+135,583
New +$14.8M 0.32% 50
2017
Q3 		– Sell
-35,000
Closed -$3.54M – 416
2017
Q2 		$3.54M Buy
+35,000
New +$3.22M 0.07% 244
2017
Q1 		– Sell
-209,935
Closed -$16M – 812
2016
Q4 		$16M Buy
+209,935
New +$15.9M 0.33% 59

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hudson Bay Capital Management's CRL Position: Q1 2018 in Review

Hudson Bay Capital Management sold out of Charles River Laboratories (CRL) in Q1 2018, closing a stake of 135,583 shares — an estimated $14.8M sold.

Hudson Bay Capital Management first reported a position in CRL in Q4 2016 and held it in 3 quarters. The position peaked at $16M in Q4 2016. 333 funds tracked by Wall St. Rank hold CRL as of Q1 2018.

  • Hudson Bay Capital Management reported no remaining Charles River Laboratories position as of Q1 2018 after selling out during the quarter.
  • Hudson Bay Capital Management sold 135,583 Charles River Laboratories shares in Q1 2018, an estimated $14.8M.
  • Hudson Bay Capital Management first reported a position in Charles River Laboratories in Q4 2016 and held it in 3 quarters.
  • Hudson Bay Capital Management's Charles River Laboratories position peaked at $16M in Q4 2016.
  • 333 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2018.

Based on Hudson Bay Capital Management's 13F filing for Q1 2018, filed 14 May 2018.